19.98MMarket Cap
LossP/E TTM
SKYE Balance Sheet
You can check out the annual or quarterly balance sheets of Skye Bioscience Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing SKYE stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Skye Bioscience Inc Have?
In its most recent quarterly, Skye Bioscience Inc had 8.35M in cash and cash equivalents.
How Much Are Skye Bioscience Inc's Total Liabilities?
Skye Bioscience Inc reported 8.29M in total liabilities as of the latest reported quarter, including 8.21M in current liabilities and 84.00K in non-current liabilities.
What Are Skye Bioscience Inc's Total Assets?
As of the latest reported quarter, Skye Bioscience Inc's total assets were 28.31M, consisting of 27.09M in current assets and 1.22M in non-current assets.
How Much Shareholders' Equity Does Skye Bioscience Inc Have?
Skye Bioscience Inc reported 20.02M in total shareholders' equity as of the latest reported quarter.